Real-time functional magnetic resonance imaging neurofeedback for the relief of distressing auditory-verbal hallucinations: methodological and empirical advances

Research output: Contribution to journalArticlepeer-review

Standard

Real-time functional magnetic resonance imaging neurofeedback for the relief of distressing auditory-verbal hallucinations : methodological and empirical advances. / Humpston, Clara; Garrison, Jane; Orlov, Natasza; Aleman, Andre; Jardri, Renaud; Fernyhough, Charles; Allen, Paul.

In: Schizophrenia bulletin, Vol. 46, No. 6, sbaa103, 02.08.2020, p. 1409-1417.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Humpston, Clara ; Garrison, Jane ; Orlov, Natasza ; Aleman, Andre ; Jardri, Renaud ; Fernyhough, Charles ; Allen, Paul. / Real-time functional magnetic resonance imaging neurofeedback for the relief of distressing auditory-verbal hallucinations : methodological and empirical advances. In: Schizophrenia bulletin. 2020 ; Vol. 46, No. 6. pp. 1409-1417.

Bibtex

@article{3054cac82b9b46f7ab67d858b7a4812d,
title = "Real-time functional magnetic resonance imaging neurofeedback for the relief of distressing auditory-verbal hallucinations: methodological and empirical advances",
abstract = "Auditory-verbal hallucinations (AVH) are often associated with high levels of distress and disability in individuals with schizophrenia-spectrum disorders. In around 30% of individuals with distressing AVH and diagnosed with schizophrenia, traditional antipsychotic drugs have little or no effect. Thus, it is important to develop mechanistic models of AVH to inform new treatments. Recently a small number of studies have begun to explore the use of real-time functional magnetic resonance imaging neurofeedback (rtfMRI-NF) for the treatment of AVH in individuals with schizophrenia. rtfMRI-NF protocols have been developed to provide feedback about brain activation in real time to enable participants to progressively achieve voluntary control over their brain activity. We offer a conceptual review of the background and general features of neurofeedback procedures before summarizing and evaluating existing mechanistic models of AVH to identify feasible neural targets for the application of rtfMRI-NF as a potential treatment. We consider methodological issues, including the choice of localizers and practicalities in logistics when setting up neurofeedback procedures in a clinical setting. We discuss clinical considerations relating to the use of rtfMRI-NF for AVH in individuals distressed by their experiences and put forward a number of questions and recommendations about best practice. Lastly, we conclude by offering suggestions for new avenues for neurofeedback methodology and mechanistic targets in relation to the research and treatment of AVH.",
author = "Clara Humpston and Jane Garrison and Natasza Orlov and Andre Aleman and Renaud Jardri and Charles Fernyhough and Paul Allen",
year = "2020",
month = aug,
day = "2",
doi = "10.1093/schbul/sbaa103",
language = "English",
volume = "46",
pages = "1409--1417",
journal = "Schizophrenia bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "6",

}

RIS

TY - JOUR

T1 - Real-time functional magnetic resonance imaging neurofeedback for the relief of distressing auditory-verbal hallucinations

T2 - methodological and empirical advances

AU - Humpston, Clara

AU - Garrison, Jane

AU - Orlov, Natasza

AU - Aleman, Andre

AU - Jardri, Renaud

AU - Fernyhough, Charles

AU - Allen, Paul

PY - 2020/8/2

Y1 - 2020/8/2

N2 - Auditory-verbal hallucinations (AVH) are often associated with high levels of distress and disability in individuals with schizophrenia-spectrum disorders. In around 30% of individuals with distressing AVH and diagnosed with schizophrenia, traditional antipsychotic drugs have little or no effect. Thus, it is important to develop mechanistic models of AVH to inform new treatments. Recently a small number of studies have begun to explore the use of real-time functional magnetic resonance imaging neurofeedback (rtfMRI-NF) for the treatment of AVH in individuals with schizophrenia. rtfMRI-NF protocols have been developed to provide feedback about brain activation in real time to enable participants to progressively achieve voluntary control over their brain activity. We offer a conceptual review of the background and general features of neurofeedback procedures before summarizing and evaluating existing mechanistic models of AVH to identify feasible neural targets for the application of rtfMRI-NF as a potential treatment. We consider methodological issues, including the choice of localizers and practicalities in logistics when setting up neurofeedback procedures in a clinical setting. We discuss clinical considerations relating to the use of rtfMRI-NF for AVH in individuals distressed by their experiences and put forward a number of questions and recommendations about best practice. Lastly, we conclude by offering suggestions for new avenues for neurofeedback methodology and mechanistic targets in relation to the research and treatment of AVH.

AB - Auditory-verbal hallucinations (AVH) are often associated with high levels of distress and disability in individuals with schizophrenia-spectrum disorders. In around 30% of individuals with distressing AVH and diagnosed with schizophrenia, traditional antipsychotic drugs have little or no effect. Thus, it is important to develop mechanistic models of AVH to inform new treatments. Recently a small number of studies have begun to explore the use of real-time functional magnetic resonance imaging neurofeedback (rtfMRI-NF) for the treatment of AVH in individuals with schizophrenia. rtfMRI-NF protocols have been developed to provide feedback about brain activation in real time to enable participants to progressively achieve voluntary control over their brain activity. We offer a conceptual review of the background and general features of neurofeedback procedures before summarizing and evaluating existing mechanistic models of AVH to identify feasible neural targets for the application of rtfMRI-NF as a potential treatment. We consider methodological issues, including the choice of localizers and practicalities in logistics when setting up neurofeedback procedures in a clinical setting. We discuss clinical considerations relating to the use of rtfMRI-NF for AVH in individuals distressed by their experiences and put forward a number of questions and recommendations about best practice. Lastly, we conclude by offering suggestions for new avenues for neurofeedback methodology and mechanistic targets in relation to the research and treatment of AVH.

U2 - 10.1093/schbul/sbaa103

DO - 10.1093/schbul/sbaa103

M3 - Article

VL - 46

SP - 1409

EP - 1417

JO - Schizophrenia bulletin

JF - Schizophrenia bulletin

SN - 0586-7614

IS - 6

M1 - sbaa103

ER -